UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The new biology of PTCL‐NOS and AITL: current status and future clinical impact

British journal of haematology, 2020-04, Vol.189 (1), p.54-66

2020

Volltextzugriff (PDF)

Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma

PloS one, 2018-01, Vol.13 (1), p.e0190468-e0190468

2018

Volltextzugriff (PDF)

Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma

Virchows Archiv : an international journal of pathology, 2014-09, Vol.465 (3), p.351-358

2014

Volltextzugriff (PDF)

Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma

PloS one, 2019-04, Vol.14 (4), p.e0215765-e0215765

2019

Volltextzugriff (PDF)

Clonal evolution in the transition from cutaneous disease to acute leukemia suggested by liquid biopsy in blastic plasmacytoid dendritic cell neoplasm

Haematologica (Roma), 2018-05, Vol.103 (5), p.e196-e199

2018

Volltextzugriff (PDF)

Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma

EJHaem, 2024-08, Vol.5 (4), p.896-899

2024

Volltextzugriff (PDF)

Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg‐type

HemaSphere, 2022-03, Vol.6 (3), p.e690-n/a

2022

Volltextzugriff (PDF)

Guidelines for the management of mature T‐ and natural killer‐cell lymphomas (excluding cutaneous T‐cell lymphoma): a British Society for Haematology Guideline

British journal of haematology, 2022-02, Vol.196 (3), p.507-522

2022

Volltextzugriff (PDF)

PD1hi cells associate with clusters of proliferating B-cells in marginal zone lymphoma

Diagnostic pathology, 2018-09, Vol.13 (1), p.74-74, Article 74

2018

Volltextzugriff (PDF)

Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing

The Lancet (British edition), 2023-07, Vol.402 (10396), p.99-102

2023

Volltextzugriff (PDF)

Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma

Scientific reports, 2018-09, Vol.8 (1), p.14216-13, Article 14216

2018

Volltextzugriff (PDF)

The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1::IRF4 fusion

British journal of haematology, 2024-10

2024

Volltextzugriff (PDF)

Follicular helper T‐cells: expanding roles in T‐cell lymphoma and targets for treatment

British journal of haematology, 2014-08, Vol.166 (3), p.326-335

2014

Volltextzugriff (PDF)

Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis

Leukemia, 2021-08, Vol.35 (8), p.2407-2411

2021

Volltextzugriff (PDF)

Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemia

Clinical cancer research, 2013-06, Vol.19 (12), p.3212-3223

2013

Volltextzugriff (PDF)

Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia

British journal of haematology, 2013-08, Vol.162 (3), p.360-370

2013

Volltextzugriff (PDF)

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper (cTfh) Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Journal of visualized experiments, 2019-01 (143)

2019

Volltextzugriff (PDF)

Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort

Advances in therapy, 2021-07, Vol.38 (7), p.3789-3802

2021

Volltextzugriff (PDF)

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Blood advances, 2024-02, Vol.8 (4), p.878-888

2024

Volltextzugriff (PDF)

Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma

Blood advances, 2020-06, Vol.4 (11), p.2392-2403

2020

Volltextzugriff (PDF)

Interleukin-2–inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells

Blood advances, 2019-03, Vol.3 (5), p.705-710

2019

Volltextzugriff (PDF)

Successful Treatment of Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type With Single-Agent Venetoclax

JCO precision oncology, 2019-12 (3), p.1-5

2019

Volltextzugriff (PDF)

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

The Lancet. Rheumatology, 2024-06, Vol.6 (6), p.e339-e351

2024

Volltextzugriff (PDF)

Circulating Tfh1

PloS one, 2018-01, Vol.13 (1), p.e0190468

2018

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(42)
magazinearticle
(1)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The new biology of PTCL‐NOS and AITL: current status and future clinical impact

Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma

Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma

Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma

Clonal evolution in the transition from cutaneous disease to acute leukemia suggested by liquid biopsy in blastic plasmacytoid dendritic cell neoplasm

Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma

Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg‐type

Guidelines for the management of mature T‐ and natural killer‐cell lymphomas (excluding cutaneous T‐cell lymphoma): a British Society for Haematology Guideline

PD1hi cells associate with clusters of proliferating B-cells in marginal zone lymphoma

Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing

Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma

The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1::IRF4 fusion

Follicular helper T‐cells: expanding roles in T‐cell lymphoma and targets for treatment

Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis

Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemia

Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia

Reconstruction of rearranged T‐cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T‐cell prolymphocytic leukemia

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper (cTfh) Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma

Interleukin-2–inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells

Successful Treatment of Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type With Single-Agent Venetoclax

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

Circulating Tfh1

Suchergebnisse filtern